Position in PCRX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$8,851,899
-$1,177,635 QoQ
Shares Held
391,677
+1.1% QoQ
Ownership
0.995%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 89.36011049921237.ToString("F0")%
Shared 0.ToString("F0")%
None 10.639889500787639.ToString("F0")%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $1,164,451,125 across 44 Drug Manufacturers - Specialty & Generic names. PCRX ranks #10 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,532,028 | $653,941,023 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
198,777 | $117,870,782 | |
| 3 | VTRS |
Viatris Inc
|
6,512,440 | $87,983,060 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,829,970 | $85,238,695 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
365,345 | $48,130,546 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
523,691 | $25,215,720 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
319,675 | $24,583,006 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
236,885 | $17,967,724 |
All Filings in PCRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,851,899 | 391,677 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $10,029,534 | 387,540 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $9,945,080 | 385,917 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $8,933,915 | 373,804 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $8,214,863 | 330,578 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $4,416,208 | 234,406 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $1,118,395 | 74,312 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $11,601,526 | 405,506 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $9,050,046 | 309,721 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $10,384,294 | 307,774 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,596,000 | 182,399 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $9,388,160 | 234,294 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $10,016,528 | 245,443 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,126,091 | 236,366 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $12,433,694 | 233,760 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,296,131 | 228,064 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $18,555,298 | 243,125 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $13,839,760 | 230,011 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $13,453,664 | 240,244 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $16,671,281 | 274,741 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $16,366,012 | 233,500 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $15,948,914 | 266,526 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $18,933,409 | 314,927 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $21,972,702 | 418,767 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $16,241,461 | 484,386 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||